Compare HELP & KELYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HELP | KELYB |
|---|---|---|
| Founded | N/A | 1946 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 854.9M | 814.8M |
| IPO Year | 2020 | 1994 |
| Metric | HELP | KELYB |
|---|---|---|
| Price | $11.95 | $22.19 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $40.12 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 11.4K |
| Earning Date | 11-12-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 1.35% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.15 |
| Revenue | N/A | ★ $5,355,600,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.70 |
| P/E Ratio | ★ N/A | $147.93 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.76 | $8.38 |
| 52 Week High | $15.15 | $125.00 |
| Indicator | HELP | KELYB |
|---|---|---|
| Relative Strength Index (RSI) | 49.79 | 46.96 |
| Support Level | $11.26 | $21.75 |
| Resistance Level | $14.35 | $24.77 |
| Average True Range (ATR) | 0.69 | 0.63 |
| MACD | -0.25 | -0.10 |
| Stochastic Oscillator | 43.46 | 9.53 |
Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.
Kelly Services Inc is a specialty talent solutions company. The company operates through three reportable segments: i) Enterprise Talent Management, which provides temporary staffing, outsourcing, and permanent placement services across industrial, contact center, and clerical roles, ii) Science, Engineering & Technology, which supplies specialized talent across multiple industries, and iii) Education, which delivers staffing, placement, and executive search services to Pre-K-12 school districts and education organizations in the United States. The majority of the company's revenue is derived from the Enterprise Talent Management segment. Geographically, it generates the maximum revenue from the United States, followed by Europe and the Asia-Pacific Region.